Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: A review
収録刊行物
-
- Molecular and Cellular Endocrinology
-
Molecular and Cellular Endocrinology 344 (1-2), 1-24, 2011-09
Elsevier BV